Baird Medical Investment (BDMD) Competitors $4.90 -0.15 (-2.97%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BDMD vs. PDEX, ZJYL, PROF, CVRX, LUCD, INFU, ICAD, OBIO, MGRM, and MBOTShould you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include Pro-Dex (PDEX), Jin Medical International (ZJYL), Profound Medical (PROF), CVRx (CVRX), Lucid Diagnostics (LUCD), InfuSystem (INFU), iCAD (ICAD), Orchestra BioMed (OBIO), Monogram Orthopaedics (MGRM), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. Baird Medical Investment vs. Pro-Dex Jin Medical International Profound Medical CVRx Lucid Diagnostics InfuSystem iCAD Orchestra BioMed Monogram Orthopaedics Microbot Medical Pro-Dex (NASDAQ:PDEX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, community ranking, profitability, earnings, institutional ownership and risk. Do analysts rate PDEX or BDMD? Pro-Dex currently has a consensus target price of $52.00, indicating a potential upside of 17.12%. Given Pro-Dex's stronger consensus rating and higher probable upside, research analysts plainly believe Pro-Dex is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is PDEX or BDMD more profitable? Pro-Dex has a net margin of 11.06% compared to Baird Medical Investment's net margin of 0.00%. Pro-Dex's return on equity of 21.68% beat Baird Medical Investment's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex11.06% 21.68% 12.40% Baird Medical Investment N/A N/A N/A Which has preferable valuation & earnings, PDEX or BDMD? Pro-Dex has higher revenue and earnings than Baird Medical Investment. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$64.12M2.26$2.13M$2.8015.86Baird Medical Investment$37.04M0.87N/AN/AN/A Which has more risk and volatility, PDEX or BDMD? Pro-Dex has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -0.74, suggesting that its stock price is 174% less volatile than the S&P 500. Does the MarketBeat Community prefer PDEX or BDMD? Pro-Dex received 156 more outperform votes than Baird Medical Investment when rated by MarketBeat users. CompanyUnderperformOutperformPro-DexOutperform Votes15661.90% Underperform Votes9638.10% Baird Medical InvestmentN/AN/A Do insiders & institutionals believe in PDEX or BDMD? 15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 47.5% of Pro-Dex shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer PDEX or BDMD? In the previous week, Pro-Dex had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Baird Medical Investment. Pro-Dex's average media sentiment score of 1.26 beat Baird Medical Investment's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baird Medical Investment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPro-Dex beats Baird Medical Investment on 12 of the 14 factors compared between the two stocks. Get Baird Medical Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDMD vs. The Competition Export to ExcelMetricBaird Medical InvestmentSurgical, Medical, And Dental Instruments And Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.26M$535.47M$5.35B$8.38BDividend YieldN/AN/A5.22%4.10%P/E RatioN/AN/A26.8419.71Price / Sales0.8719.11391.39116.98Price / CashN/AN/A38.2534.62Price / BookN/AN/A6.794.50Net IncomeN/AN/A$3.23B$248.18M7 Day Performance-4.67%-2.39%4.07%1.14%1 Month Performance-11.71%2.75%12.52%15.20%1 Year PerformanceN/A70.80%16.83%6.56% Baird Medical Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDMDBaird Medical InvestmentN/A$4.90-3.0%N/AN/A$32.26M$37.04M0.00N/APDEXPro-Dex2.6471 of 5 stars$40.27-9.1%$52.00+29.1%+130.9%$131.32M$64.12M20.03140News CoveragePositive NewsGap UpHigh Trading VolumeZJYLJin Medical InternationalN/A$0.90+8.2%N/A-74.2%$129.93M$23.50M0.00245PROFProfound Medical2.5443 of 5 stars$4.28-7.6%$11.50+168.7%-39.2%$128.63M$10.68M-3.19150High Trading VolumeCVRXCVRx2.9248 of 5 stars$4.75-0.4%$14.50+205.3%-15.6%$123.77M$51.29M-1.77160Gap UpHigh Trading VolumeLUCDLucid Diagnostics3.0297 of 5 stars$1.10-2.7%$3.50+218.2%+39.8%$115.92M$4.35M-0.9670Gap UpINFUInfuSystem2.4561 of 5 stars$5.48+2.0%$13.00+137.2%N/A$115.17M$134.86M91.35410News CoverageHigh Trading VolumeICADiCAD0.4759 of 5 stars$3.71+3.1%N/A+141.5%$101.83M$19.61M-28.54140News CoverageAnalyst ForecastGap UpHigh Trading VolumeOBIOOrchestra BioMed2.831 of 5 stars$2.65flat$14.20+435.8%-43.6%$101.53M$2.64M-1.654Gap UpMGRMMonogram Orthopaedics3.2412 of 5 stars$2.63-1.5%$5.40+105.3%+40.1%$92.81M$364,999.00-5.6028Earnings ReportGap UpMBOTMicrobot Medical1.8406 of 5 stars$2.55+1.2%$9.00+252.9%+162.1%$88.60MN/A-3.1920Positive NewsEarnings ReportGap Up Related Companies and Tools Related Companies PDEX Competitors ZJYL Competitors PROF Competitors CVRX Competitors LUCD Competitors INFU Competitors ICAD Competitors OBIO Competitors MGRM Competitors MBOT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDMD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BDMD Stock Free BDMD Stock Alerts